Flare Therapeutics is based in Philadelphia. It has raised $287M in total funding. Latest round: Series C.
Flare Therapeutics is based in Philadelphia. Flare Therapeutics has raised $287M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in June 2026. The round record for Flare Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Third Rock Ventures, Nextech Invest, Pfizer Ventures, Boxer Capital, GordonMD Global Investments, Invus and 5 others. 11 distinct backers are named across the disclosed rounds.
Totals shown for Flare Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Philadelphia and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026